| P2093 | author name string | Jason M Meyer | |
| | Ailing Ji | |
| | Nancy R Webb | |
| | Joanne M Wroblewski | |
| | Deneys R van der Westhuyzen | |
| | Frederick C de Beer | |
| | Maria C de Beer | |
| | Victoria P Noffsinger | |
| P2860 | cites work | Inflammatory markers of coronary risk | Q73088431 |
| | Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice | Q81248705 |
| | Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | Q81300622 |
| | Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice | Q82753371 |
| | Serum amyloid A, the major vertebrate acute-phase reactant | Q28145306 |
| | Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake | Q28294881 |
| | Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein | Q33280880 |
| | Serum amyloid A3 does not contribute to circulating SAA levels | Q33418206 |
| | Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2) | Q33741235 |
| | Biliary sterol secretion is not required for macrophage reverse cholesterol transport | Q34035681 |
| | Impact of serum amyloid A on high density lipoprotein composition and levels | Q34187954 |
| | Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. | Q34386663 |
| | ATP binding cassette G1-dependent cholesterol efflux during inflammation | Q34503409 |
| | Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport | Q34776276 |
| | Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease | Q35749982 |
| | Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host | Q35753611 |
| | HDL cholesterol and protective factors in atherosclerosis | Q35806051 |
| | C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients | Q36456535 |
| | Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? | Q36492920 |
| | HDL cholesterol transport during inflammation | Q36758120 |
| | Inflammation impairs reverse cholesterol transport in vivo. | Q37077796 |
| | Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol | Q37339259 |
| | Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver | Q38300931 |
| | Serum amyloid A has little effect on high density lipoprotein (HDL) binding to U937 monocytes but may influence HDL mediated cholesterol transfer | Q39059465 |
| | Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss | Q39782322 |
| | Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1- or ABCA7-dependent manner | Q40293994 |
| | Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. | Q40381699 |
| | Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux | Q40390167 |
| | Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner | Q40498547 |
| | Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells | Q40517353 |
| | Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano | Q41855576 |
| | Influence of apolipoprotein A-I domain structure on macrophage reverse cholesterol transport in mice | Q41952869 |
| | Impaired phagocytic mechanism in annexin 1 null macrophages | Q42186020 |
| | The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I. | Q42938904 |
| | Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo | Q44090023 |
| | Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1. | Q44138778 |
| | Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. | Q45212260 |
| | Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition | Q47206788 |
| | SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells | Q48010257 |
| | Revised nomenclature for serum amyloid A (SAA). Nomenclature Committee of the International Society of Amyloidosis. Part 2. | Q48762928 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | feces | Q496 |
| | macrophage | Q184204 |
| P304 | page(s) | 283486 | |
| P577 | publication date | 2013-01-30 | |
| P1433 | published in | Journal of Lipids | Q26842585 |
| P1476 | title | The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A. | |
| P478 | volume | 2013 | |